Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
ObjectiveTo investigate the monotherapy for gestational trophoblastic neoplasia (GTN) patients with FIGO/WHO prognostic score of 5–6.MethodsThe low-risk GTN patients from 2012 to 2019 were enrolled. The study is a retrospective report to analyze the efficacy and safety of single-agent chemotherapy a...
Main Authors: | Li Kemin, Zhang Mengpei, Yin Rutie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1035170/full |
Similar Items
-
First-line monodrug chemotherapy in low-risk gestational trophoblastic neoplasia: a network meta-analysis
by: Fang Zhou, et al.
Published: (2024-01-01) -
Exploring the real cause of hemoptysis: A case of pulmonary tumor embolism in a young woman with accompanying pulmonary metastasis of gestational trophoblastic neoplasia
by: Qun Hu, et al.
Published: (2023-04-01) -
Primary hepatic metastatic epitheloid trophoblastic tumor of the uterus treated with multimodal therapy including pembrolizumab and thermoablation. Case report of an extremely rare disease and review of the literature
by: M. Helbig, et al.
Published: (2023-10-01) -
Rescoring of Patients with Gestational Trophoblastic Neoplasia Using Modified Scoring System By Figo
by: Taner Turan, et al.
Published: (2006-12-01) -
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia
by: Yuanyuan Liu, et al.
Published: (2023-01-01)